CompletedNot Applicable

Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.

France539 participantsStarted 2016-07

Plain-language summary

The purpose of this study is to assess the frequency of cachexia and the management of cachexia and associated symptoms in a patient population with non-small cell lung cancer (NSCLC).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient 18 years of age and older * Patient with NSCLC * Patient who has been informed of the study and who has signed a patient information leaflet for France or an informed consent for Belgium * Patient able to complete a self-assessment questionnaire Exclusion Criteria: * Patient unable to consent and/or unable to sign the patient information form in France or an informed consent in Belgium * Patient with a complete resection of an early stage NSCLC * History of head and neck cancer

What they're measuring

Frequency of Cachexia According to Modified Fearon Criteria

Timeframe: Day1

Trial details

NCT IDNCT02968979

SponsorChugai Pharma France

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2016-10

Results submitted2017-12-18

View on ClinicalTrials.gov More Non-small Cell Lung Cancer trials